| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 07/13/2004 | CA2069248C Steroid derivatives of pregna-4,9(11),17(20)-trien-3-one, their preparation, their application to the preparation of steroidic compounds of pregna-4,9(11),16-trien-3,20 and novel intermediates-dione, |
| 07/01/2004 | WO2004055039A1 Steroid compounds with anti-tumor activity |
| 07/01/2004 | CA2509283A1 Steroid compounds with anti-tumor activity |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/09/2004 | EP1426352A2 Intermediates for the sythesis of vitamin D and steroid derivatives |
| 06/02/2004 | CN1152045C Method for preparing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and the intermediate products obtained in said method |
| 05/26/2004 | EP1420769A2 Lipid profile modulation with steroids |
| 05/20/2004 | US20040097478 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 05/19/2004 | EP1265618A4 Anaesthetic composition |
| 05/06/2004 | WO2004021975A3 An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| 05/06/2004 | WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 05/04/2004 | CA2098148C Process for the preparation of 16-alpha-methyl steroids |
| 05/04/2004 | CA2097678C Process for preparing a 11-keto steroid derivative |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 04/28/2004 | EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 04/22/2004 | WO2003102012A3 New etonogestrel esters |
| 04/21/2004 | CN1146574C Synthesis method of pregnen ketoalcohol compound |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/14/2004 | EP1406636A2 System and method for the large scale labeling of compounds with radiohalogens |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/08/2004 | WO2003092578A3 Further syntheses of cyproterone acetate |
| 04/07/2004 | CN1144813C Noval pregnane derivatives without substituting group at 17šŒlpha position, itsapplication as medicine preparing method and intermediate thereof and related compounds |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 03/30/2004 | CA2243504C New 19-nor-pregnene derivatives |
| 03/24/2004 | EP1399464A1 Process to prepare 11beta, 17alpha, 21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 03/24/2004 | EP1399463A1 PROCESS TO PREPARE 11$g(b),17$g(a),21-TRIHYDROXY-6$g(a)-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 03/18/2004 | WO2004021975A2 An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| 03/18/2004 | WO2003102012A9 New etonogestrel esters |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | US20040053904 9-fluoro-11 beta-hydroxy-16 alpha-methyl-1,4-pregnadiene-3,20-dione 17-cyclopropanecarboxylate derivative for the treatment of respiratory system disorders such as bronchial asthma |
| 03/17/2004 | CN1142176C Halcinonide producing process |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/11/2004 | US20040048841 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 03/10/2004 | CN1481246A Preventives/ermedies for inflammatory airway diseases |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/18/2004 | CN1475494A Cleaning production technique of 16-dehydro pregnenetrolone and its same kind compound |
| 02/12/2004 | DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids |
| 02/11/2004 | CN1137691C heterogeneous contraception preparation based on natural estrogen |
| 02/05/2004 | WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
| 01/27/2004 | US6683197 Process for the production of 4,4-dimethyl-5α-cholesta-8,14,24-trien-3β-01 and intermediate products in process (I) |
| 01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/21/2004 | CN1469749A Use of antiprogestins for the induction of apoptosis in a cell |
| 01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 01/14/2004 | EP1380302A1 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 01/14/2004 | EP1150683B9 Utilization of dienogest in high doses |
| 01/08/2004 | US20040006240 Process to prepare 11beta,17alpha ,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 01/01/2004 | US20040002484 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/30/2003 | US6670350 Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| 12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
| 12/18/2003 | WO2003038523A3 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 12/11/2003 | WO2003102012A2 New etonogestrel esters |
| 12/10/2003 | EP1368308A1 Cannabinoid receptor ligands |
| 12/10/2003 | EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 12/09/2003 | US6660132 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
| 11/26/2003 | CN1458162A Process for extracting saponins from white fleece-flower root |
| 11/25/2003 | US6653491 Method for producing 4,4-dimethyl-3β-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/13/2003 | WO2003092578A2 Further syntheses of cyproterone acetate |
| 11/13/2003 | US20030211162 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 11/13/2003 | CA2482997A1 Further syntheses of cyproterone acetate |
| 11/05/2003 | EP1359154A1 Further syntheses of cyproterone acetate |
| 10/23/2003 | US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 10/21/2003 | CA2072053C 16-methyl substituted steroids derived from pregna 1,4-diene 3,20-dione, their preparation and application to the preparation of 16-methylene steroids and novel intermediate compounds |
| 10/08/2003 | EP1150683B1 Utilization of dienogest in high doses |
| 09/25/2003 | WO2003078376A1 Nk1 antagonists |
| 09/25/2003 | CA2478211A1 Nk1 antagonists |
| 09/23/2003 | CA2073760C Steroidal organic substance crystallization method and compounds thereby obtained |
| 09/18/2003 | WO2002062750A9 Cannabinoid receptor ligands |
| 09/17/2003 | EP1344526A1 Preventives/ermedies for inflammatory airway diseases |
| 09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
| 09/17/2003 | EP1070082B1 Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/09/2003 | US6617319 Animal extracts; uterine contractions; isolation by distillation, flash chromatography |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 09/03/2003 | EP0947504B1 16-ene-vitamin d derivatives |
| 08/28/2003 | US20030162759 Preventing or treating cardiovascular disease including atherosclerosis |
| 08/27/2003 | EP1338273A2 Crystalline triamcinolone acetonide produced by a milling process |
| 08/21/2003 | US20030158167 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/13/2003 | EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 08/13/2003 | CN1436170A Vitamin D derivs. |
| 08/13/2003 | CN1435429A Buxanines compounds with cardiovascular activity and cardiovascular and cerebrovascular medicine using them as active component |
| 08/13/2003 | CN1435428A Cyclovirobuxine D salt and its preparation and use, and process for preparing said preparation |
| 08/07/2003 | WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor |
| 08/07/2003 | WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens |
| 07/30/2003 | EP1135403B1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/24/2003 | WO2003059931A1 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS |
| 07/23/2003 | EP1328276A1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/16/2003 | EP1326617A1 Use of antiprogestins for the induction of apoptosis in a cell |
| 07/03/2003 | WO2003053991A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 07/03/2003 | CA2470364A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/25/2003 | EP1077765B1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 06/19/2003 | WO2003029267A3 METHOD OF PRODUCING 17β-(SUBSTITUTED)-3-OXO-Δ1,2-4-AZASTEROIDS AND INTERMEDIATES |
| 06/17/2003 | US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |